Tandem
Tandem
Turning an early-stage healthcare AI vision into a focused, disciplined go-to-market strategy.
“Healthcare is complex and you cannot boil the ocean. Bryan at TechCXO understands this.”
— Sheila Pande, CEO, Founder
Overview
Tandem is an AI-powered clinical decision support platform designed to help primary care and OB/GYN providers better identify and manage mental health needs within the flow of care.
As screening for anxiety, depression, and maternal mental health becomes more common, many providers lack practical tools to deliver timely follow-on care. Tandem addresses this gap by acting as a clinical intelligence layer, helping clinicians move from screening to action within their existing workflows.
Founder Sheila Pande brought Tandem to TechCXO at a pivotal stage. The company had a strong vision, a compelling product concept, and growing interest from investors, providers, and strategic partners. However, translating that momentum into a clearer, market-ready path to commercialization required additional focus and discipline.
To move forward, Tandem needed to sharpen its positioning, clarify its commercialization path, and prioritize the proof points that would drive adoption and growth.
Challenges
At the time of engagement, Tandem faced a common set of early-stage commercialization challenges:
- A broad long-term vision made it difficult to clearly articulate a focused near-term use case
- The commercialization story was not yet fully defined for providers, investors, and channel partners
- The economic value and ROI of the platform needed to be more clearly framed for buyers
- There was no clear, repeatable path to pilots, validation, and early revenue
- The company was balancing product development, fundraising, and market entry simultaneously
Like many emerging healthcare companies, Tandem had strong insight into the problem it was solving but needed to translate that into a clear, actionable story the market could quickly understand and adopt.
Goals
To move from early vision to commercial traction, Tandem needed to:
- Define a clear and focused near-term use case for the platform
- Position the product for adoption in primary care and OB/GYN settings
- Strengthen the value proposition, including ROI and economic impact
- Support pilot conversations and early sales efforts with targeted materials
- Build a credible path to pilots, validation, and early revenue generation
Solutions
Tandem engaged TechCXO Partner Bryan Dennstedt as a fractional CTO and strategic advisor to help refine the company’s product positioning and commercialization strategy.
Working closely with the founder, Bryan focused on aligning Tandem’s vision with a clear, market-ready path to adoption.
Key initiatives included:
- Defining a focused near-term market position centered on clinical decision support for primary care and OB/GYN mental health workflows
- Clarifying the company’s value proposition around the gap between screening and actionable care
- Refining messaging for different stakeholders, including providers, investors, and channel partners
- Developing a stronger ROI narrative based on earlier intervention, avoided downstream costs, and improved care delivery
- Establishing a practical path to pilots and early validation through targeted outreach and partnership development
- Strengthening commercialization materials, including pitch decks and outreach messaging
- Encouraging the pursuit of concrete validation signals, such as letters of intent and pilot commitments
These efforts helped Tandem move from a broad, vision-driven narrative to a more focused and commercially actionable go-to-market strategy.
Bryan works with early-stage and growth companies to align product, technology, and commercialization strategy, helping founders turn complex ideas into scalable, market-ready businesses.
Partner, Fractional CTO/CIO
As fractional CTO and strategic advisor, Bryan Dennstedt helped Tandem translate its vision into a focused go-to-market strategy by aligning product positioning, economic value, and commercialization priorities to accelerate adoption.
Outcome
Through TechCXO’s strategic guidance, Tandem emerged with a clearer and more focused path to commercialization.
The company refined its near-term positioning around clinical decision support for mental health in primary care and OB/GYN settings, aligning its product narrative with a specific and actionable use case. This provided a stronger foundation for engaging providers, partners, and investors.
Tandem also developed a more disciplined approach to commercialization. Pilot conversations, outreach efforts, and partnership discussions were supported by clearer messaging, stronger ROI framing, and more targeted materials. The company gained a better-defined path to validation, including a focus on securing letters of intent, pilot opportunities, and early adoption signals.
Just as importantly, Sheila gained a strategic sounding board who could help translate Tandem’s mission into a more market-ready story without losing the core purpose behind the company’s work. This allowed the business to maintain its long-term vision while building a more practical and executable path to growth.
Sharpened positioning…
Tandem defined a clear, near-term use case aligned with real clinical workflows and market needs.
Commercial readiness…
Improved messaging, ROI framing, and validation strategy created a more actionable path to pilots and early adoption
“Healthcare is complex and you cannot boil the ocean. Bryan at TechCXO understands this. From our first meeting, it was clear he didn’t just have technical depth; he knew how to work with healthcare clients, their corporate constraints, their implementation expectations, and the unique pace of this industry. That perspective was a window into potential I hadn’t seen from my own experience, and honestly, it was one of those moments where you just know you’ve found the right person.
When you find a technical leader who leads with the first sale rather than the shiniest solution, and who brings a fundamentally different but complementary lens to the same goals, something accelerates. For us, that meant leaning into AI together, discovering applications across multiple business models, and building a complex HIPAA-compliant product at a fraction of the prior budget. All of this under the resource constraints that are simply the reality of building something early stage, especially as a female founder.
This is the partnership structure that will define early stage companies in the age of AI. Finding a technical partner through TechCXO who truly understands your industry, your architecture and security requirements, and most importantly your sales process, is no longer a nice to have. For founders moving quickly with AI, it is the difference between building something that scales and building something that stalls. Bryan embodies exactly that kind of partnership, and it has made all the difference.”
- Sheila Pande CEO, Founder
